Composition and method for detecting cancer with technetium...

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/40

G01N 33/534 (2006.01) A61K 39/395 (2006.01)

Patent

CA 1186620

ABSTRACT OF THE DISCLOSURE This invention discloses F(ab')2 or Fab fragments of antibodies to: a) human chorionic gonadotropin (hCG), hCG alpha subunit, hCG beta subunit, or an hCG-like material; or b) other tumor specific or tumor associated molecules, to include carcinoembryonic antigen (CEA), alpha fetoprotein (AFP), human melanoma associated antigens, human sarcoma associated antigens or other antigens, which are radiolaheled with technetium-99m (Tc-99m). When the F(ab')2 or Fab fragments of antibody to such tumor associated antigens are injected intra- venously into a patient, the radiolabeled composition accumulates at tumor sites. The accumulation of the cancer seeking radiopharmaceutical at tumor sites permits detection by external gamma scintigraphy. Thus, the composition is useful in the monitoring, localization and detection of cancer in the body.

439805

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Composition and method for detecting cancer with technetium... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition and method for detecting cancer with technetium..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for detecting cancer with technetium... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1330539

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.